Prevention of injection pain due to propofol by dezocine: a comparison with lidocaine

Indian J Pharmacol. 2013 Nov-Dec;45(6):619-21. doi: 10.4103/0253-7613.121376.

Abstract

Objectives: The aim of this study was to investigate the efficacy of dezocine (DEZ) versus placebo control (CON) and 2% lidocaine (LID) in prevention of injection pain due to DEZ.

Materials and methods: A prospective randomized double-blind, placebo-CON study was conducted in 75 adults, American Society of Anesthesiologists physical status I or II, scheduled to undergo an elective surgery. A total of 25 patients were randomly assigned to one of the three groups, thus CON, group LID and group DEZ. The groups received either 2 ml of normal saline or 2 ml 2% LID or 2 mg/2 ml DEZ, respectively, as pre-treatment. Propofol was injected 1 min later. A blinded researcher assessed the patient's pain level using a four point verbal rating scale.

Results: Less patients experienced pain due to propofol injection in the LID (40%) and DEZ (28%) groups compared with the CON (84%) group (P < 0.05). Six patients (24%) in the CON group reported severe pain during propofol injection but none in the other two groups.

Conclusion: Pre-treatment with DEZ decreases propofol injection pain as effectively as LID.

Keywords: Dezocine; injection pain; lidocaine; propofol.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analgesics, Opioid / therapeutic use*
  • Anesthetics, Intravenous / administration & dosage*
  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use*
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pain / prevention & control*
  • Placebos
  • Propofol / administration & dosage*
  • Prospective Studies
  • Tetrahydronaphthalenes / therapeutic use*

Substances

  • Analgesics, Opioid
  • Anesthetics, Intravenous
  • Bridged Bicyclo Compounds, Heterocyclic
  • Placebos
  • Tetrahydronaphthalenes
  • dezocine
  • Propofol